• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK SE & CO. KG SELECTRA RIGHT-45; LEAD DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK SE & CO. KG SELECTRA RIGHT-45; LEAD DELIVERY SYSTEM Back to Search Results
Model Number 375535
Device Problems Improper or Incorrect Procedure or Method (2017); No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/06/2020
Event Type  malfunction  
Event Description
We received notification from a hospital on (b)(6) 2020 that an expired catheter was used during an implant procedure.The procedure occurred on (b)(6) 2020, but the ubd of the catheter was (b)(6) 2019.No adverse patient side effects have been reported.No part of the catheter remains in the patient.The catheter was discarded by the hospital after use.Should additional information be received, this file will be updated.
 
Manufacturer Narrative
As of today, the medical device is not available for analysis, therefore the device itself could not be investigated.The analysis is thus based on the inspection of the manufacturing documents of the device.The manufacturing process for this device was re-investigated.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing process.There is no data available to biotronik demonstrating the sterility of selectra catheters beyond ubd.Should additional information or the device itself become available for analysis, the investigation will be updated.
 
Manufacturer Narrative
The analysis conclusion codes have been updated by the manufacturer.As of today, the medical device is not available for analysis, therefore the device itself could not be investigated.The analysis is thus based on the inspection of the manufacturing documents of the device.The manufacturing process for this device was re-investigated.All production steps had been performed accordingly.There was no sign of any inconsistency during the manufacturing process.There is no data available to biotronik demonstrating the sterility of selectra catheters beyond ubd.Should additional information or the device itself become available for analysis, the investigation will be updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SELECTRA RIGHT-45
Type of Device
LEAD DELIVERY SYSTEM
Manufacturer (Section D)
BIOTRONIK SE & CO. KG
woermannkehre 1
berlin 12359
MDR Report Key9739140
MDR Text Key180810920
Report Number1028232-2020-00864
Device Sequence Number1
Product Code DQY
UDI-Device Identifier04035479116798
UDI-Public04035479116798
Combination Product (y/n)N
PMA/PMN Number
K110461
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup,Followup
Report Date 02/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/21/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2019
Device Model Number375535
Device Catalogue NumberSEE MODEL NO.
Device Lot Number10172492
Was Device Available for Evaluation? No
Date Manufacturer Received03/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-